跳至主要内容
临床试验/ISRCTN85372848
ISRCTN85372848已完成未知

A randomised controlled trial of high-dose immunosuppression in paraquat poisoning

South Asian Clinical Toxicology Research Collaboration (SACTRC) (Sri Lanka)0 个研究点目标入组 299 人开始时间: 2006年8月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
299

研究概览

简要总结

2018 results in https://pubmed.ncbi.nlm.nih.gov/29098875/ (added 01/07/2021)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Patients with a history of acute paraquat poisoning
  • 2. Presenting within 24 hours of paraquat ingestion with evidence of paraquat intoxication by urinary dithionite test

排除标准

  • 1. Under 14 years
  • 2. Pregnant
  • 3. Systolic blood pressure of less than 70 mmHg, unresponsive to one litre fluid challenge, Glasgow Coma Score (GCS) less than 8/15, or cyanosis
  • 4. Already received cyclophosphamide or methylprednisolone for this episode of poisoning
  • 5. Allergic to cyclophosphamide, methylprednisolone, dexamethasone or mesna
  • 6. Unable to give consent, or not accompanied by a relative, where the hospital consultant prefers that consent be obtained from a relative rather than the consultant looking after the patient
  • 7. Present more than 24 hours after paraquat ingestion

研究者

发起方
South Asian Clinical Toxicology Research Collaboration (SACTRC) (Sri Lanka)

相似试验